# EDGAR Filing Document

**Accession Number:** 0001949139
**File Stem:** 0001949139-26-000004
**Filing Date:** 2026-5
**Character Count:** 2804
**Document Hash:** e0543536ac1c350449d757cc83dab563
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001949139-26-000004.hdr.sgml**: 20260508

**ACCESSION NUMBER**: 0001949139-26-000004

**CONFORMED SUBMISSION TYPE**: C-AR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260508

**DATE AS OF CHANGE**: 20260508

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Diant Pharma Inc.
- **CENTRAL INDEX KEY:** 0001949139

**ORGANIZATION NAME:**
- **EIN:** 842432789
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-35280
- **FILM NUMBER:** 26956653

**BUSINESS ADDRESS:**
- **STREET 1:** 130 UTOPIA RD. STE 12
- **CITY:** MANCHESTER
- **STATE:** CT
- **ZIP:** 06042
- **BUSINESS PHONE:** 774-462-2227

**MAIL ADDRESS:**
- **STREET 1:** 130 UTOPIA ROAD, UNIT 12
- **CITY:** MANCHESTER
- **STATE:** CT
- **ZIP:** 06042

### Attached PDF Documents

**Attachment 1:** `form_car.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Diant Pharma Inc.

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 07-02-2019

**Physical Address:** 130 Utopia Road, Unit 12, Manchester, CT, 06042

**Issuer Website:** www.diantpharma.com

**Is there a Co-Issuer?:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 9

**Total Assets (Most Recent Fiscal Year):** $1,690,032.00

**Total Assets (Prior Fiscal Year):** $1,766,948.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $29,330.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $55,455.00

**Accounts Receivable (Most Recent Fiscal Year):** $103,276.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $265,049.00

**Short-Term Debt (Prior Fiscal Year):** $104,358.00

**Long-Term Debt (Most Recent Fiscal Year):** $190,406.00

**Long-Term Debt (Prior Fiscal Year):** $0.00

**Revenues/Sales (Most Recent Fiscal Year):** $1,530,991.00

**Revenues/Sales (Prior Fiscal Year):** $849,070.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $881,307.00

**Cost of Goods Sold (Prior Fiscal Year):** $279,180.00

**Taxes Paid (Most Recent Fiscal Year):** $15,292.00

**Taxes Paid (Prior Fiscal Year):** $12,727.00

**Net Income (Most Recent Fiscal Year):** $-538,167.00

**Net Income (Prior Fiscal Year):** $-414,051.00

### Signatures

**Issuer:** Diant Pharma Inc.

**Signature:** Antonio Costa

**Title:** CEO

---

**Signature:** Antonio Costa

**Title:** CEO

**Date:** 05-07-2026

---

**Signature:** Bryan J. Kotlarz

**Title:** CFO

**Date:** 05-07-2026